Summary
Objectives:
- Describe the epidemiology of obesity and its intersection with diabetes.
- Understand the role of glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) for diabetes and weight loss.
- Prescribe effective and necessary lifestyle modifications as an accompaniment to pharmacological therapy.
Note: If you share or use these presentations, or any parts thereof, please ensure you always credit the Ohio Cardiovascular and Diabetes Health Collaborative (Cardi-OH) and provide a link to Cardi-OH.org. CME is not offered for viewing the recording.
Featured Speakers
Benjamin O'Donnell, MD
The Ohio State University